Tempest Therapeutics Inc (TPST) Live Share Price, Invest From India

Tempest Therapeutics Inc Stock Performance

as on May 5, 2026 at 6:08 am IST

Day's Low
Day's High
$2.03
Day's Price Range
$2.18
$2.14
5.14%
Downside
1.87%
Upside
52 Week's Low
52 Week's High
$1.20
52-Week Price Range
$6.12
$2.14
43.93%
Downside
185.75%
Upside

Tempest Therapeutics Inc share price movements today

Previous Close: $2.04
Open: $2.05
Volume: 351.4K
Day's Low - High: $2.03 - $2.18
52 Week Low - High: $1.20 - $6.12

Tempest Therapeutics Inc Historical Returns

1 Month Return: + 28.3 %
3 Month Return: -14.29 %
1 Year Return: -41.63 %
3 Year Return: -85.4 %
5 Year Return: 0 %

Tempest Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tempest Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.3M

EPS (TTM)

-1.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-26.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-203.63%

Tempest Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tempest Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tempest Therapeutics Inc	BUY	$29.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.5B	125.06%	74.59	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.8B	97.31%	27.71	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.97	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.5B	44.57%	17.12	29.65%

Stock Returns calculator for Tempest Therapeutics Inc Stock including INR - Dollar returns

The Tempest Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tempest Therapeutics Inc investment value today

Current value as on today

₹68,957

Returns

-₹31,043

(-31.04%)

Returns from Tempest Therapeutics Inc Stock

-₹38,857 (-38.86%)

Dollar Impact

₹7,814 (+7.81%)

Analyst Recommendation on Tempest Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tempest Therapeutics Inc. Average target price of $11

Tempest Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tempest Therapeutics Inc.

What analysts predicted

80.55%UPSIDE

Target Price

$11

Current Price

$2.14

Analyzed by

12 Analysts

Target

$11.00

Tempest Therapeutics Inc target price $11, a slight upside of 80.55% compared to current price of $2.14. According to 12 analysts rating.

Tempest Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Tempest Therapeutics Inc Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 5, 2026 to May 5, 2026

Change:12% versus previous 30 day period

Tempest Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-6	-7	-7	-9	-10	-13	-10	-7	-3	-4
EBITDA	-6	-7	-7	-9	-10	-13	-10	-7	-3	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-7	-7	-9	-10	-13	-10	-7	-3	-4
Income Tax Expense	0	0	0	-	-	0	-	-	-	-
Net Income	-6	-7	-7	-9	-10	-13	-10	-7	-3	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-2842.18%	-2234.57%	0.00%	0.00%	0.00%

Tempest Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	-	-	-	-	-	-
Gross Profit	-4	0	0	-1	-1	0	0	-
Operating Income	-81	-20	-19	-26	-34	-29	-42	-26
EBITDA	-79	-84	-18	-26	-33	-27	-40	-25
Interest Expense	0	-	0	1	1	1	1	0
Depreciation	-	-	0	0	0	0	0	0
Income Before Tax	-82	-84	-19	-28	-35	-29	-41	-26
Income Tax Expense	0	0	0	1	1	-	-41	-
Net Income	-82	-84	-19	-28	-35	-29	-41	-26
Net Profit Margin	-12597.24%	-28670.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tempest Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-7	-7	-9	-10	-13	-10	-7	-3	-4
Operating Cash Flow	-6	-7	-5	-10	-10	-8	-8	-6	-3
Investing Cash Flow	0	0	0	0	0	-	-	-	-
Financing Cash Flow	34	0	4	1	17	0	1	0	3
Change in Cash	28	-6	-1	-8	7	-8	-7	-6	0

Tempest Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-84	-27	-44	-19	-28	-35	-29	-41	-26
Operating Cash Flow	-20	-23	-41	-19	-25	-31	-27	-33	-26
Investing Cash Flow	0	1	3	0	0	0	0	0	-
Financing Cash Flow	-4	78	26	34	59	11	35	24	4
Change in Cash	-26	55	-9	15	33	-20	8	-8	-22

Global Institutional Holdings in Tempest Therapeutics Inc

Funds	Holdings
Tower Research Capital LLC	0%
Versant Venture Management LLC	2%
Versant Venture Management LLC	1.88%
Sabby Management LLC	1.25%
Global Retirement Partners, LLC.	0%

See all

Insights on Tempest Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TPST stock has moved up by 18.6%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 57.4%
NO EFFECT
Against Peers
In the last 3 years, Tempest Therapeutics Inc has experienced a drawdown of -85.4%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 78.4%

About Tempest Therapeutics Inc

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Organisation	Tempest Therapeutics Inc
Headquarters	2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Industry	Biotechnology
CEO	Dr. Matthew Angel Ph.D.
E-voting on shares	Click here to vote

Key Management of Tempest Therapeutics Inc

Name	Title
Mr. Nicholas Maestas	CFO, Head of Corporate Strategy & Secretary
Dr. Matthew Angel Ph.D.	President, CEO & Director
Mr. Justin Trojanowski CPA	Corporate Controller, Treasurer & Principal Accounting Officer
Dr. Andrew Fang Ph.D.	Head of Business Development

FAQs

What is Tempest Therapeutics Inc share price today?

Tempest Therapeutics Inc share price today is $2.14 as on May 5, 2026 at 12:38 am IST. Tempest Therapeutics Inc share today touched a day high of $2.18 and a low of $2.03.

What is the 52 week high and 52 week low for Tempest Therapeutics Inc share?

Tempest Therapeutics Inc share touched a 52 week high of $6.12 on October 15, 2025 and a 52 week low of $1.2 on January 15, 2026. Tempest Therapeutics Inc stock price today i.e. May 5, 2026 at 12:38 am IST is trending at $2.14,which is 65.00% down from its 52 week high and 78.33% up from its 52 week low.

What is Tempest Therapeutics Inc's market capitalisation today?

Tempest Therapeutics Inc market capitalisation is $0.00T as on May 5, 2026 at 12:38 am IST.

How to invest in Tempest Therapeutics Inc Stock (TPST) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tempest Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tempest Therapeutics Inc Shares that will get you 0.7009 shares as per Tempest Therapeutics Inc share price of $2.14 per share as on May 5, 2026 at 12:38 am IST.

What is the minimum amount required to buy Tempest Therapeutics Inc Stock (TPST) from India?

Indian investors can start investing in Tempest Therapeutics Inc (TPST) shares with as little as ₹95.067 or $1 (as of May 5, 2026 at 12:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Tempest Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 5, 2026 at 12:39 am IST). Based on Tempest Therapeutics Inc share’s latest price of $2.14 as on May 5, 2026 at 12:38 am IST, you will get 4.6729 shares of Tempest Therapeutics Inc. Learn more about fractional shares .